Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbohydrate sulfotransferase 10 (CHST10) is an enzyme that catalyzes the transfer of sulfate from 3′-phosphoadenylyl sulfate (PAPS) to the C-3 hydroxyl position of terminal glucuronic acid residues on both protein- and lipid-linked oligosaccharides. CHST10 is critically involved in the biosynthesis of the HNK-1 carbohydrate structure, which is widely expressed on neural cell adhesion molecules and plays an essential role in neural development and synaptic plasticity. It is also involved in sulfating steroid hormones, including glucuronidated estrogens and androgs, thus influencing hormonal cycles and fertility. Pathogenic variants in CHST10 have been associated with certain forms of muscular dystrophy (e.g., muscular dystrophy-dystroglycanopathy type A, Walker-Warburg syndrome), suggestive of a role in neuromuscular and neurodevelopmental pathologies. No approved drugs, specific therapeutic ligands, or biomarkers are currently listed for this target in the available sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbohydrate sulfotransferase 10 (CHST10).